The clinical features of patients with NSCLC harboring RET fusion (RET fusion + NSCLC) include younger age (median age around 60 years), equal prevalence in both sexes, adenocarcinoma histology, poorly differentiated tumors, and no or low exposure to tobacco [28,29]. The gene discussed is RET; the disease is adenocarcinoma.